Trial Profile
Dose Sparing and Safety-Enhancing Effects of an IGF-I-Based Dosing Regimen in Short Children Treated with Growth Hormone in a 2-Year Randomized Controlled Trial: Therapeutic and Pharmacoeconomic Considerations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2012
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Short stature
- Focus Therapeutic Use
- 24 Jul 2012 New trial record